Cutaneous side-effects of EGFR inhibitors and their management

Area of Science:

• Oncology
• Dermatology
• Pharmacology

Background:

• Epidermal growth factor receptor (EGFR) inhibitors are vital in treating metastatic cancers.
• EGFR plays a crucial role in tumor development and progression.
• EGFR is also essential for normal skin and hair follicle function.

Purpose of the Study:

• To provide a comprehensive overview of cutaneous side effects associated with EGFR inhibitor therapy.
• To discuss the therapeutic strategies for managing these dermatological adverse events.

Main Methods:

• Literature review of studies on EGFR inhibitors and their side effects.
• Analysis of the incidence and timing of various skin reactions.
• Summary of current treatment options for EGFR inhibitor-induced dermatopathies.

Main Results:

• Acneiform eruptions are the most frequent early side effect.
• Xerosis and fissures commonly appear in later treatment stages.
• Paronychia and hair growth alterations are less common, typically observed after prolonged treatment.

Conclusions:

• Cutaneous side effects are a common and significant issue during EGFR inhibitor therapy.
• Understanding the spectrum of these side effects is crucial for patient management.
• Appropriate therapeutic interventions can help mitigate these adverse events, improving patient compliance and outcomes.